Hedge Fund - Woodline Partners

Regeneron Pharmaceuticals Inc. (REGN) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2025 - Q4 (2025-12-31) $50,146,850 0.19% 64,968 $679.11
2 2025 - Q3 (2025-09-30) $34,278,228 0.16% 60,964 $565.42
3 2025 - Q2 (2025-06-30) $30,858,450 0.16% 58,778 $558.13
4 2025 - Q1 (2025-03-31) $67,366,008 0.44% 106,217 $687.82
5 2024 - Q4 (2024-12-31) $73,568,730 0.49% 103,279 $839.22
6 2024 - Q3 (2024-09-30) $104,511,127 0.88% 99,417 $1112.86
7 2024 - Q2 (2024-06-30) $191,179,204 1.82% 181,897 $969.40
8 2024 - Q1 (2024-03-31) $164,202,719 1.51% 170,602 $950.88
9 2023 - Q4 (2023-12-31) $149,388,346 1.62% 170,090 $823.50
10 2023 - Q3 (2023-09-30) $112,393,293 1.31% 136,572 $785.91
11 2023 - Q2 (2023-06-30) $34,247,053 0.4% 47,662 $771.00
12 2023 - Q1 (2023-03-31) $126,800,936 1.72% 154,321 $754.21
13 2022 - Q4 (2022-12-31) $115,072,605 1.53% 159,493 $737.86
14 2022 - Q3 (2022-09-30) $129,065,000 1.8% 187,357 $629.39
15 2022 - Q2 (2022-06-30) $31,207,000 0.48% 52,792 $650.01
16 2022 - Q1 (2022-03-31) $73,679,000 1.19% 105,494 $632.65
17 2021 - Q4 (2021-12-31) $56,992,000 0.81% 90,246 $614.83
18 2021 - Q3 (2021-09-30) $45,900,000 0.74% 75,846 $620.82
19 2021 - Q2 (2021-06-30) $43,487,000 0.81% 77,859 $506.62
20 2021 - Q1 (2021-03-31) $87,956,000 1.95% 185,899 $486.87
21 2020 - Q4 (2020-12-31) $9,761,000 0.25% 20,204 $539.80
22 2020 - Q3 (2020-09-30) $0 0% 0 $606.33
23 2020 - Q2 (2020-06-30) $19,160,000 0.75% 30,722 $567.62
24 2020 - Q1 (2020-03-31) $13,417,000 0.95% 27,477 $412.49

The displayed share prices are average quarterly stock market prices.